Cargando…
Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers
BACKGROUND: Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in randomized controlled trials; however, uptake among women at high-risk for developing breast cancer remains low. The aim of this study is to identif...
Autores principales: | Jones, Tarsha, Silverman, Thomas, Guzman, Ashlee, McGuinness, Julia E., Trivedi, Meghna S., Kukafka, Rita, Crew, Katherine D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354269/ https://www.ncbi.nlm.nih.gov/pubmed/35927732 http://dx.doi.org/10.1186/s12911-022-01954-y |
Ejemplares similares
-
Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial
por: Jones, Tarsha, et al.
Publicado: (2021) -
Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study
por: Ro, Vicky, et al.
Publicado: (2022) -
Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention
por: Crew, Katherine D., et al.
Publicado: (2019) -
Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting
por: Kukafka, Rita, et al.
Publicado: (2018) -
Introducing a Comprehensive Informatics Framework to Promote Breast Cancer Risk Assessment and Chemoprevention in the Primary Care Setting
por: Finkelstein, Joseph, et al.
Publicado: (2017)